George D. Maynard
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Molecular spectroscopy and chirality, Neuropeptides and Animal Physiology, Chemical Synthesis and Analysis, Receptor Mechanisms and Signaling
Most-Cited Works
- → 2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity(1990)68 cited
- → [3.3] Sigmatropy within 1-vinyl-2-alkenyl-7,7-dimethyl-exo-norbornan-2-ols. The first atropselective oxyanionic Cope rearrangement(1990)60 cited
- → Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury(2020)55 cited
- → Targeting memory processes with drugs to prevent or cure PTSD(2012)53 cited
- → Relevance of oxyanion stereochemistry to chirality transfer in anionic oxy-Cope rearrangements(1992)43 cited
- → Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists(2019)37 cited
- → Boat/chair topographic stereoselection during anionic oxy-Cope rearrangement of 1-alkenyl-2-cyclopentenyl-endo-norbornan-2-ols(1990)30 cited
- → The Newly Developed CRF1-Receptor Antagonists, NGD 98-2 and NGD 9002, Suppress Acute Stress-Induced Stimulation of Colonic Motor Function and Visceral Hypersensitivity in Rats(2013)30 cited
- → Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist(2008)30 cited
- → Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptors(1996)29 cited